FORA Capital’s AbbVie ABBV Stock Holding History

FORA Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$240K	Buy	+954	New	+$205K	0.02%	326
2025 Q4	–	Sell	-5,349	Closed	-$1.24M	–	412
2025 Q3	$1.24M	Buy	+5,349	New	+$1.09M	0.22%	128
2024 Q1	–	Sell	-30,229	Closed	-$4.68M	–	390
2023 Q4	$4.68M	Buy	+30,229	New	+$4.41M	0.4%	79
2023 Q3	–	Sell	-56,652	Closed	-$7.63M	–	439
2023 Q2	$7.63M	Buy	+56,652	New	+$8.31M	1.08%	15
2023 Q1	–	Sell	-21,045	Closed	-$3.4M	–	496
2022 Q4	$3.4M	Buy	+21,045	New	+$3.23M	0.55%	45
2022 Q3	–	Sell	-3,852	Closed	-$590K	–	392
2022 Q2	$590K	Sell	3,852 -18,216	-83%	-$2.78M	0.12%	220
2022 Q1	$3.61M	Buy	22,068 +18,100	+456%	+$2.63M	0.65%	31
2021 Q4	$537K	Buy	+3,968	New	+$469K	0.21%	137
2021 Q3	–	Sell	-21,394	Closed	-$2.41M	–	336
2021 Q2	$2.41M	Buy	+21,394	New	+$2.41M	0.45%	49
2020 Q3	–	Sell	-27,314	Closed	-$2.68M	–	620
2020 Q2	$2.68M	Buy	27,314 +21,379	+360%	+$1.88M	0.92%	10
2020 Q1	$452K	Buy	+5,935	New	+$506K	0.1%	264

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FORA Capital's ABBV Position: Q2 2026 in Review

FORA Capital opened a new position in AbbVie (ABBV) in Q2 2026: 954 shares worth $240K. The stake represents 0.02% of the portfolio and ranks #326 among its holdings. This is a return to the name: FORA Capital previously reported a position in ABBV as recently as Q3 2025.

FORA Capital first reported a position in ABBV in Q1 2020 and has held it in 11 quarters since. The position peaked at $7.63M in Q2 2023. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

FORA Capital held 954 shares of AbbVie worth $240K as of Q2 2026.
AbbVie was a new FORA Capital position in Q2 2026.
AbbVie made up 0.02% of FORA Capital's portfolio in Q2 2026, its #326 holding.
FORA Capital first reported a position in AbbVie in Q1 2020 and has held it in 11 quarters since.
FORA Capital's AbbVie position peaked at $7.63M in Q2 2023.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.